Human cloning: the alchemists of the 3rd millennium?

November 20, 2003 - By Prof. Jean-François Bourge

Renowned researcher in immunocancerology, Prof. Dr. Jean-François Bourge will share his vision of fundamental research, human cloning and new therapeutic approaches to curing cancer.

Jean-François Bourge is currently collaborating with American teams at Harvard Medical School. His research focuses on in vivo cell therapy, proposing new forms of anti-tumor "vaccination" using cells transformed in vitro.

progresso della ricerca medica

After studying medicine and then science, Jean-François Bourge's academic career led him to study bioinformatics at Arts et Métiers. He was an auditor at the Ecole Nationale d'Administration. However, his main activity remains fundamental research. He is a Cancer Immunology Researcher at Hôpital St LOUIS.

In addition to his activities as a researcher, he was Deputy Mayor in charge of health and school catering in the 18th arrondissement of Paris. He is President of a 1,200-strong socio-cultural association and a founding member of the Rotary Club de Paris Avenirwhere he is Chief of Protocol.